These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31884656)

  • 1. Critical Role of Trophic Factors in Protecting Müller Glia: Implications to Neuroprotection in Age-Related Macular Degeneration, Diabetic Retinopathy, and Anti-VEGF Therapies.
    Xu B; Zhang H; Zhu M; Le YZ
    Adv Exp Med Biol; 2019; 1185():469-473. PubMed ID: 31884656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF production and signaling in Müller glia are critical to modulating vascular function and neuronal integrity in diabetic retinopathy and hypoxic retinal vascular diseases.
    Le YZ
    Vision Res; 2017 Oct; 139():108-114. PubMed ID: 28601428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF as a Trophic Factor for Müller Glia in Hypoxic Retinal Diseases.
    Fu S; Dong S; Zhu M; Le YZ
    Adv Exp Med Biol; 2018; 1074():473-478. PubMed ID: 29721978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF Mediates Retinal Müller Cell Viability and Neuroprotection through BDNF in Diabetes.
    Le YZ; Xu B; Chucair-Elliott AJ; Zhang H; Zhu M
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34068807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANALYSIS OF RETINAL DEGENERATIVE CHANGES IN DIABETIC MACULAR EDEMA AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Boiko EV; Maltsev DS
    Retina; 2018 Jul; 38(7):1324-1330. PubMed ID: 28492427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does laser still have a role in the management of retinal vascular and neovascular diseases?
    Shah AM; Bressler NM; Jampol LM
    Am J Ophthalmol; 2011 Sep; 152(3):332-339.e1. PubMed ID: 21742309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aging and retinal vascular diseases].
    Takagi H
    Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):207-30; discussion 231. PubMed ID: 17402563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endophthalmitis Rates after Bilateral Same-Day Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
    Borkar DS; Obeid A; Su DC; Storey PP; Gao X; Regillo CD; Kaiser RS; Garg SJ; Hsu J;
    Am J Ophthalmol; 2018 Oct; 194():1-6. PubMed ID: 29981738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of VEGF in diseases of the retina].
    Barquet LA
    Arch Soc Esp Oftalmol; 2015 Mar; 90 Suppl 1():3-5. PubMed ID: 25925044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of laser photocoagulation in the anti-vascular endothelial growth factor therapy era].
    Wang F; Zhang P; Sun X
    Zhonghua Yan Ke Za Zhi; 2015 Dec; 51(12):885-7. PubMed ID: 26888269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema.
    Zehetner C; Kirchmair R; Huber S; Kralinger MT; Kieselbach GF
    Br J Ophthalmol; 2013 Apr; 97(4):454-9. PubMed ID: 23385630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress.
    Caldwell RB; Bartoli M; Behzadian MA; El-Remessy AE; Al-Shabrawey M; Platt DH; Liou GI; Caldwell RW
    Curr Drug Targets; 2005 Jun; 6(4):511-24. PubMed ID: 16026270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canadian preference and trends survey results for anti-VEGF treatment of macular edema.
    Rayat JS; Grewal PS; Whelan J; Tennant MT; Choudhry N
    Can J Ophthalmol; 2016 Jun; 51(3):233-7. PubMed ID: 27316276
    [No Abstract]   [Full Text] [Related]  

  • 14. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
    Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW
    Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological inhibition of N-methyl d-aspartate receptor promotes secretion of vascular endothelial growth factor in müller cells: effects of hyperglycemia and hypoxia.
    Cervantes-Villagrana AR; Garcia-Román J; González-Espinosa C; Lamas M
    Curr Eye Res; 2010 Aug; 35(8):733-41. PubMed ID: 20673050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aflibercept: A review of its effect on the treatment of exudative age-related macular degeneration.
    Papadopoulos Z
    Eur J Ophthalmol; 2019 Jul; 29(4):368-378. PubMed ID: 30813810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB.
    Avery RL; Castellarin AA; Steinle NC; Dhoot DS; Pieramici DJ; See R; Couvillion S; Nasir MA; Rabena MD; Maia M; Van Everen S; Le K; Hanley WD
    Retina; 2017 Oct; 37(10):1847-1858. PubMed ID: 28106709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor responders to bevacizumab pharmacotherapy in age-related macular degeneration and in diabetic macular edema demonstrate increased risk for obstructive sleep apnea.
    Nesmith BL; Ihnen M; Schaal S
    Retina; 2014 Dec; 34(12):2423-30. PubMed ID: 25062438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential antiedematous effects of intravitreous anti-VEGF, unrelated to VEGF neutralization.
    Behar-Cohen F; Dernigoghossian M; Andrieu-Soler C; Levy R; Cohen R; Zhao M
    Drug Discov Today; 2019 Aug; 24(8):1436-1439. PubMed ID: 31173913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular Anti-VEGF therapy for diabetic retinopathy: the role of VEGF in the pathogenesis of diabetic retinopathy.
    Simó R; Sundstrom JM; Antonetti DA
    Diabetes Care; 2014 Apr; 37(4):893-9. PubMed ID: 24652720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.